As shown in figure 5b, h-Prune serum concentrations was observed to be significantly higher (P< 0.0005) in patients with stage I and II NSCLC than in the healthy controls (mean, 291.2±162 pg/ml and 99.3±52 pg/ml, respectively). The gene discussed is PRUNE1; the disease is non-small cell lung carcinoma.